The acute, transforming avian leukemogenic viruses generally exhibit a restricted set of potential target cells. In vitro studies have demonstrated that avian myeloblastosis virus (AMV) is the most restricted of this group and represents the only one which fails to transform fibroblast cultures (14) . When this virus is injected into chickens (2) or quail (23) , it produces the well-described myeloblastic leukemia. All other neoplastic responses which have been observed after the injection of the AMV complex have relatively long latent periods (8) and are known to be also induced by the MAV-1 and MAV-2 helper viruses present in the virus stock (2, 21) . Transformation in vitro by AMV appears to occur in tissues which contain immature hemopoietic cells or high levels of myeloid cells (1, 16) . The cells derived from in vivo tumors and the cells derived from in vitro transformation of hemopoietic cells are relatively homogenous and represent similar, if not identical, phenotypes. Thus, in vitro systems appear to provide a reasonable copy of in vivo processes, and the target cells appear to be restricted to cells in the myeloid lineage.
Most cell populations which can be utilized as target cells contain a mixture of myeloid cells at various stages of cell differentiation or maturation (1) . This is particularly true of the most commonly utilized bone marrow cells (13, 15) . In their early experiments, Moscovici et al. suggested that the adherent macrophage population can serve as target cells (20, 21) . These results have been confirmed more rigorously by us (12) . Although the results with bone marrow cell populations raise the possibility that less mature cells may also serve as target cells for infection by AMV, the exact characterization of the target cells has remained unclear. The use of cell separation procedures has refined the description of these target cells; however, the low efficiencies of the assays employed limit the interpretation of the conclusions reached (13, 15) . An additional complicating factor is that successful infection and successful transformation were * Corresponding author.
generally measured together as a composite. Little attempt has been made to investigate the possible differential sensitivities to infection alone. It is known that infection depends on continued cell proliferation (7, 12) and that for macrophages, this process is controlled by specific growth factors (27) .
The 12-day chicken embryo yolk sac contains a high concentration of hemopoietic progenitor cells. For cells in the myeloid lineages, this population consists almost entirely of cells at the blast cell stage, before the expression of any myeloid-specific markers (5; E. M. Durban, Ph.D. thesis, University of Pennsylvania, Philadelphia, 1980; E. M. Durban and D. Boettiger; manuscript in preparation). About 5% of the nonerythroid cells in fresh primary cultures express the earliest markers of either the granulocyte or the macrophage lineage. In vitro, in the presence of chicken serum factors, this cell population undergoes a single, relatively synchronous wave of cell differentiation: granulopoiesis reaching a peak at 3 days and macrophage differentiation reaching a peak at 5 days. There does not appear to be any significant progenitor cell self-renewal in this system. The nature of this population makes it useful in analysis of whether myeloid cell progenitors are susceptible to AMV.
MATERIALS AND METHODS
Cells and viruses. Twelve-to fourteen-day SPAFAS chicken embryo yolk sacs were dissected free of other embryonic membranes. The yolk sacs from four to eight embryos were pooled, washed with TD buffer (138 mM NaCl, 5 mM KCl, 5.6 mM glucose, 0.56 mM Na2HPO4, 19 mM Tris) until the majority of the yolk was removed, and the sacs were minced with scalpels. The minced yolk sacs were further dispersed by using an E-C Cellector with 100-mesh screen; this procedure produced a good single-cell suspension. The and cellular debris remained on top of the 50% FicollHypaque, and erythroid cells were pelleted at the bottom. The interface fraction was taken and cultured in BT88 medium (22) containing 10% tryptose phosphate, 5% calf serum (Flow Laboratories), and 5% chicken serum (GIBCO Laboratories) (referred to as complete BT88) at a density of 2 x 107 cells per ml.
AMV was provided as 0.5-g pellets by Life Sciences Inc., under a contract from the Division of Cancer Cause and Prevention, National Cancer Institute. Each pellet was suspended in 10 ml of TD buffer by using a Dounce homogenizer. Suspended virus was frozen at -70°or diluted 1:10 in medium with 5% calf serum and filtered through a filter (0.22-,um pore size) for sterilization. The virus was further diluted to 10-2 and portioned for storage at -70°C. All virus dilutions were calculated based on the initial virus suspension at 10°C. The actual virus concentration in the undiluted stock was calculated to be between 10-and 100-fold that found in leukemic chicken plasma.
Agar colony assay. 
RESULTS
Characteristics of the agar colony for AMV. The assay system we used was based on the original observations of Dodge and Moscovici (11) on the production of agar colonies by AMV-infected and normal uninfected cells derived from in vitro cultures of yolk sac cells. In their experiments, conditioned medium from primary chicken embryo cultures was used as a source of colony-stimulating activity (CSA). In our hands, pretested lots of normal chicken serum proved to be a better source of CSA for macrophages. Titration of the chicken serum lot used determined that 10% chicken serum produced the highest number of normal macrophage-type colonies from normal yolk sac cells.
A linear relationship between the number of colonies per plate and the number of cells plated was obtained (Fig. 1 ). This result suggested that the level of CSA (in the chicken serum) was not limiting. The maximum number of transformed colonies ranged from 100 to 300 per 106 cells in different experiments. This is about 10-fold higher than that reported by Graf et al. (16) . The difference may be explained by the higher level of CSA used in our assay system (4).
This colony assay was modified to serve as a titration assay for virus stocks similar to that devised previously for bone marrow-derived cells (16) for bone marrow (16) . This plateau could result either from saturation of potential target cells (resulting either from state of cell differentiation or from physiological state) or from a limitation in the virus stock. Since the virus stock contained both AMV and MAV-1 and MAV-2 helper viruses as well as noninfectious virus particles, an unfavorable ratio of AMV to the remaining particles could, at a high virus input, saturate the virus receptors and interfere with infection by AMV. This phenomenon of early interference has been described by Steck and Rubin (26) .
Test for viral interference and estimate of receptors. To provide a source of noninfectious virus particles which could still occupy receptor sites, a 10-l dilution of stock 3 was UV irradiated. Of this irradiated virus stock, 0.1 ml was used to infect 2 x 107 yolk sac cells, and no transformed colonies were produced. This proved to be the limit of the assay, since the undiluted virus stock was too thick to be irradiated efficiently with UV. The stock of UV-irradiated virus was serially diluted, and each dilution was mixed with a constant amount of infectious virus, corresponding to a final dilution of 2 x 10-3. Figure 3 shows the titration curves for stock 3 and the mixture in the same experiment. Stock 3 gave a AMV stock at 2 h after plating. In the experiment shown here (Fig. 2) (16) have presented a similar assay for AMV which uses bone. marrow. Their plasma stocks gave titers of 2.5 x 1 CFU/ml which, after an allowance of an additional 20-fold dilution of our stock to reach normal plasma levels, still left a 500-fold difference. This could be due to a difference in titer in their plasma stock or to a difference in assay sensitivity or both.
In addition to producing a linear portion for titration at low virus inputs, all titrations produced a plateau region at high virus inputs (Fig. 2) . A similar result has also been obtained Fig. 2 . The mixture produced a plateau at low levels of irradiated virus, but a sharp decrease was observed starting near the 10-2 dilution. Since it was possible that the virus stock itself was toxic and hence this decrease was nonspecific, serial dilutions of the irradiated virus only were used to mock infect yolk sac cells, and the effect on normal macrophage colony formation was determined (Fig. 3) . These results suggested that the high virus concentrations were indeed toxic and inhibited normal macrophage colonies; however, the slope of the inhibition was less than that observed in the interference assay. It appears that both early interference and toxic factors contributed to the inhibition of transformed colony formation with virus inputs of greater than the 10-2 dilution. Thus, the plateau region from 10-2 to 10-4 appears to be due to the limitation in the number of virus target cells and not to a property of the virus stock used.
These (Table 3) , whereas the secondary infections produced only 8 x 104 by day 8. The decreased rate of cell proliferation did contribute to a loss of sensitivity for detection of virus production; however, this demonstrated that secondary infection did not make an important contribution to the total number of transformants produced in this system. Given the relatively high efficiency of the assay, this implied that the blast cell stage of macrophage progenitors was susceptible to infection by AMV. The kinetics of cell transformation could be followed in the liquid culture system by evaluating morphologically the number of transformed cells present on each successive day after infection by AMV. Since cell multiplication may also contribute to the total cell number, the rate of cell multiplication of the transformed cells was determined by evaluating the mitotic index for transformed cells on each day. Initially 2 x 107 cells were infected; this produced 1.5 x 106 transformed cells at 2 days. This amount corresponds to 7.5% of the original cell number or about 4% of the cells from day 0 accounting for cell proliferation (Table 3) . Measurement of the mitotic index revealed that there was an increase from 0.2 at 2 days to 0.75 at 5 days. The 0.2 level was similar to that of normal promonocytes and monocytes at the same time of culture (Table 1) ; the 0.75 indicated a cell doubling time of about 3 days, which was the same as that we measured for established transformed cells and similar to that observed by others for AMV-transformed cells in vitro (3, 17) . Thus, the initial morphological transformation preceded the increase in cell growth rate.
To evaluate the synchrony of cell transformation, the mitotic index was used to approximate the growth rate of the transformants and hence, to determine the proportion of new transformation events which would be required to generate the number of transformants actually observed on the next day. Of the transformation events, 60% occurred on day 2, with the remainder split between days 3 and 4. After day 4, all subsequent increases could be accounted for by the multiplication of already transformed cells. This time course correlates with the disappearance of the blast cells (which were reduced to 40% by day 1 and were essentially gone by day 2) and the appearance of prornonocytes and monocytes which made their first appearance on day 1 (12) . Additional experiments with both yolk sac and bone marrow (13, 15, 16) have provided evidence for AMV targets being less mature than adherent macrophages. With the present data, it appears likely that all stages of macrophage differentiation, from the committed progenitor to the mature macrophage, may serve as targets for infection and give rise to transformed progeny cells.
An agar colony assay for AMV in primary yolk sac cells was presented which compared favorably with the previous macrophage focus assay (21) and bone marrow colony assays (13, 16) . Even this assay appears to be rather inefficient in comparison to the liquid culture transformation. To achieve saturation levels capable of transforming about 5% of the total population required 2 x 1 CFU for 2 x i07 cells or a multiplicity of infection of 0.001 CFU per cell. This finding suggests that the efficiency of the agar assay may be 0.1 to 1% of potential transformants producing a colony. For the gradieht-purified population, the estimated efficiency based on target cell calculations described above was about 0.5%. That potential AMV transformants exhibited such a low plating efficiency strengthens the conclusion that the committed macrophage progenitors, and not the low level contamination of promonocytes, were serving as the principle target for infection in these assays.
The initial target cell in the yolk sac copurified with the normal macrophage colony-forming cell on the Percoll gradients. Since even the more mature macrophages score in this assay (11) , this result merely indicated that target cells were restricted to the macrophage lineage. This conclusion was strengthened by recent results which demonstrate that both granulocyte and erythrocyte precursors are separated from the macrophage precursors by this gradient (M. Olsen and D. Boettiger, manuscript in preparation). The major target cell in yolk sac and the major target cell in bone marrow represent different cell populations and can be distinguished on the basis of their requirements for CSA. The yolk sac targets require three-to fivefold more CSA for colony formation (4). Since CSA is required for differentiation (19) as well as for survival and growth (27) , and the bone marrow contains a substantial number of cells which express some macrophage markers (13) , it appears that the target cell in yolk sac is, on the average, more primitive than that in bone marrow. The kinetics of transformation of yolk sac cells in liquid culture required a minimum of 2 days; whereas the transformation of fibroblasts by Rous sarcoma virus at saturating levels of virus input has been reported to occur in 28 h (18) . Given the high mitotic index of the primary yolk sac cells and their susceptibility to infection, it is unlikely that the cell cycle-dependent events in virus replication were responsible for the delay. Both this and the normal development of the macrophage progenitors to promonocytes and monocytes during this period argue for differentiation steps being involved in the delay (7; Durban, Ph.D. thesis; Durban and Boettiger, in preparation).
Transformation which is dependent on the process of cell differentiation has also been implicated in other systems. Samarut and Gazzolo (24) have described the process for avian erythroblastosis virus in which the target cell for infection was the erythroid burst-forming unit (BFUe), but the transformed cell was more similar to the more mature erythroid colony-forming unit (CFUe). They 
